Management of an individual worker with occupational asthma

  • Sherwood Burge
Part of the Progress in Inflammation Research book series (PIR)


The aim of management of an individual with occupational asthma is to preserve their health and wealth, preferably to leave their employer in business, and to prevent other workers from developing occupational asthma. To do this a confident diagnosis must be made. Occupational asthma should be suspected when asthma symptoms improve on days away from work or on holiday. As these questions have many false-positive answers, the diagnosis needs objective confirmation. The most appropriate first test is to carry out good quality peak flow measurements every 2 hours for about 3 weeks during periods of usual work exposure. Specific IgE is helpful for most highmolecular-weight allergens, and can be used to monitor allergen avoidance. Specific bronchial challenge testing is required in new or difficult situations. Non-specific bronchial hyperresponsiveness is not sufficiently sensitive to use as a screening test for those requiring further investigation. Once a diagnosis has been made workers should be separated into those in whom further (usual level) exposure is unlikely to cause further deterioration in their asthma (mostly those with acute irritantinduced asthma) and those who are sensitised to a workplace agent in whom further usual level exposure commonly leads to deteriorating asthma. There is a hierarchy of control methods when exposure must be eliminated or substantially reduced, going from substitution, source exposure control and individual protection. Examples of each strategy are given. The availability and scope of compensation schemes also affect management; some facilitate re-training and ensuring income preservation much better than others. Successful management nearly always involves cooperation between the affected worker, their employer and their compensation scheme. An accurate clinical diagnosis is a requirement for all of these.


Skin Prick Test Peak Expiratory Flow Individual Worker Occupational Asthma Confidence Inter 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hudson P, Cartier A, Pineau L, Lafrance M, St Aubin JJ, Dubois JV et al. Follow-up of occupational asthma caused by crab and various agents. J Allergy Clin Immunol. 1985; 76: 682–688CrossRefPubMedGoogle Scholar
  2. 2.
    Park HS, Nahm DH. Prognostic factors for toluene diisocyanate-induced occupational asthma after removal from exposure. Clin Exp Allergy. 1997; 27(10): 1145–1150CrossRefPubMedGoogle Scholar
  3. 3.
    Piirilä PL, Nordman H, Keskinen HM, Luukkonen R, Salo SP, Tuomi T et al. Long-term follow-up of hexamethylene diisocyanate-, diphenylmethane diisocyanate-, and toluene diisocyanate-induced asthma. Am J Respir Crit Care Med. 2000; 162(2 Pt 1): 516–522PubMedGoogle Scholar
  4. 4.
    Rosenberg N, Garnier R, Rousselin X, Mertz R, Gervais P. Clinical and socio-professional fate of isocyanate-induced asthma. Clin Allergy. 1987; 17: 55–61CrossRefPubMedGoogle Scholar
  5. 5.
    Ross DJ, McDonald JC. Health and employment after a diagnosis of occupational asthma: a descriptive study. Occup Med. 1998; 48: 219–225CrossRefGoogle Scholar
  6. 6.
    Tarlo SM, Banks D, Liss G, Broder I. Outcome determinants for isocyanate induced occupational asthma among compensation claimants. Occup Environ Med. 1997; 54(10): 756–761CrossRefPubMedGoogle Scholar
  7. 7.
    Nicholson PJ, Cullinan P, Newman Taylor AJ, Burge PS, Boyle C. Evidence based guidelines for the prevention, identification, and management of occupational asthma. Occup Environ Med. 2005; 62: 290–299CrossRefPubMedGoogle Scholar
  8. 8.
    Burge PS. Non-specific bronchial hyper-reactivity in workers exposed to toluene diisocyanate, diphenyl methane di-isocyanate and colophony. Eur J Respir Dis (Suppl). 1982; 123: 91–96Google Scholar
  9. 9.
    Douglas JD, McSharry C, Blaikie L, Morrow T, Miles S, Franklin D. Occupational asthma caused by automated salmon processing. Lancet. 1995; 346(8977): 737–740CrossRefPubMedGoogle Scholar
  10. 10.
    Grammer LC, Shaughnessy MA, Henderson J, Zeiss CR, Kavich DE, Collins MJ et al. A clinical and immunologic study of workers with trimellitic-anhydride-induced immunologic lung disease after transfer to low exposure jobs. Am Rev Respir Dis. 1993; 148: 54–57PubMedGoogle Scholar
  11. 11.
    Merget R, Schulte A, Gebler A, Breitstadt R, Kulzer R, Berndt ED et al. Outcome of occupational asthma due to platinum salts after transferral to low-exposure areas. Int Arch Occup Environ Health 1999; 72(1): 33–39CrossRefPubMedGoogle Scholar
  12. 12.
    Pisati G, Baruffini A, Zedda S. Toluene diisocyanate induced asthma: Outcome according to persistence or cessation of exposure. Br J Ind Med. 1993; 50: 60–64PubMedGoogle Scholar
  13. 13.
    Beach J, Russell K, Blitz S, Hooton N, Spooner C, Lemiere C et al. A systematic review of the diagnosis of occupational asthma. Chest. 2007; 131(2): 569–578CrossRefPubMedGoogle Scholar
  14. 14.
    Niezborala M, Garnier R. Allergy to complex platinum salts: A historical prospective cohort study. Occup Environ Med. 1996; 53(4): 252–257CrossRefPubMedGoogle Scholar
  15. 15.
    Linnett PJ, Hughes EG. 20 years of medical surveillance on exposure to allergenic and non-allergenic platinum compounds: The importance of chemical speciation. Occup Environ Med. 1999; 56: 191–196CrossRefPubMedGoogle Scholar
  16. 16.
    Rioux JP, Malo JL, L’Archeveque J, Rabhi K, Labrecque M. Workplace-specific challenges as a contribution to the diagnosis of occupational asthma. Eur Respir J. 2008; 32: 997–1003CrossRefPubMedGoogle Scholar
  17. 17.
    Krop E, Doekes G, Stone M, Aalberse R, van der Zee JS. Spreading of occupational allergens: Laboratory animal allergens on hair-covering caps and in mattress dust of laboratory animal workers. Occup Environ Med. 2007; 64(4): 267–272CrossRefPubMedGoogle Scholar
  18. 18.
    Venables KM, Dally MB, Burge PS, Pickering CAC, Newman Taylor AJ. Occupational asthma in a steel coating plant. Br J Ind Med. 1985; 42(8): 517–524PubMedGoogle Scholar
  19. 19.
    Tran S, Hoyle J, Niven RM, Francis HC. The paper recycling industry, hydroxylamine and occupational asthma: two case reports. Thorax. 2007; 62 suppl 3: A130Google Scholar
  20. 20.
    Cathcart M, Nicholson P, Roberts D, Bazley M, Juniper C, Murray P et al. Enzyme exposure, smoking and lung function in employees in the detergent industry over 20 years. Medical Subcommittee of the UK Soap and Detergent Industry Association. Occup Med. 1997; 47(8): 473–478CrossRefGoogle Scholar
  21. 21.
    Cullinan P, Harris JM, Newman Taylor AJ, Hole AM, Jones M, Barnes F et al. An outbreak of asthma in a modern detergent factory. Lancet. 2000; 356: 1899–1900CrossRefPubMedGoogle Scholar
  22. 22.
    Hnizdo E, Yu L, Freyder L, Attfield M, Lefante J, Glindmeyer HW. The precision of longitudinal lung function measurements: Monitoring and interpretation. Occup Environ Med. 2005; 62(10): 695–701CrossRefPubMedGoogle Scholar
  23. 23.
    Burge PS, O’Brien IM, Harries MG. Peak flow rate records in the diagnosis of occupational asthma due to colophony. Thorax. 1979; 34(3): 308–316CrossRefPubMedGoogle Scholar
  24. 24.
    Anees W, Huggins V, Pavord I, Robertson AS, Burge PS. Occupational asthma due to low molecular weight agents: Eosinoiphilic and non-eosinophilic variants. Thorax. 2002; 57: 231–236CrossRefPubMedGoogle Scholar
  25. 25.
    Leynadier F, Doudou O, Gaouar H, Le Gros V, Bourdeix I, Guyomarch-Cocco L et al. Effect of omalizumab in health care workers with occupational latex allergy. J Allergy Clin Immunol. 2004; 113: 360–361.CrossRefPubMedGoogle Scholar

Copyright information

© Birkhäuser / Springer Basel 2010

Authors and Affiliations

  • Sherwood Burge
    • 1
  1. 1.Heart of England NHS Foundation TrustBirmingham Heartlands HospitalBirminghamUK

Personalised recommendations